Birdsong

Timothy Taylor is pleased to present Birdsong, a group exhibition of works showcasing influential voices in contemporary British art, at the gallery’s London space. Spanning genres and generations, Birdsong presents an eclectic group of works by UK-based and British artists including Tomo Campbell, Daniel Crews-Chubb, Tracey Emin, Emma Fineman, Rowley Haynes, Sophie von Hellermann, Chantal Joffe, Idris Khan, Rachel Kneebone, Richard Long, Sahara Longe, Annie Morris, Richard Patterson, Andrew Pierre Hart, Paula Rego, Catherine Repko, Anne Rothenstein, Yinka Shonibare CBE, Antonia Showering, and Rachel Whiteread. This program supports The Royal Marsden, a world-leading cancer research centre and hospital in London.

Birdsong features over 25 works in various media from a diverse mix of established artists and rising talents, and includes several works from artists in the gallery’s program. With many pieces drawn directly from the artists’ studios, the exhibition creates a unique opportunity to explore new ideas and cultivate unique dialogues.

All profits from this exhibition will benefit The Royal Marsden Cancer Charity’s mission to improve the lives of people affected by cancer – supporting an institution where Taylor himself was treated for Hodgkin’s Lymphoma as a young man. The exhibition’s title is inspired by the title of Sebastian Faulks’ book of the same name, evoking a symbol of hope and resilience in the face of mortality.

“My family has supported The Royal Marsden’s world-leading research efforts since my own experience with lymphoma. I have seen their passion first-hand, and I thank every participating artist for their generosity in supporting this cause. Birdsong embodies the joy that art can lend even in the most challenging circumstances.” – Timothy Taylor

About The Royal Marsden Cancer Charity
The Royal Marsden Cancer Charity raises money solely to support The Royal Marsden, a world-leading cancer hospital which opened its doors in 1851. It is a centre of excellence with an international reputation for groundbreaking research and pioneering the very latest in cancer treatments and technologies, as well as specialising in cancer diagnosis and education. Their mission is to make national and global contributions to cancer research and treatment.